Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Shenqu Xiaoshi Oral Liquid for gastrointestinal symptoms in children with respiratory infections
ChiCTR2500114578Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, open-label trial of shen qu xiao shi oral liquid in Airways Infection, None, diarrhea and 1 more (2 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoint: Improvement rate of gastrointestinal symptoms. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
shen qu xiao shi oral liquid
03
Conditions
Airways Infectiondiarrheaspleen and stomach deficiency syndrome
Beyond the preview
Go deeper on ChiCTR2500114578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114578.